Page 29 - SFHN April 2021 Revised

TM

Americanna Laboratories

Appoints Wyman Dickey

as New CEO

Americanna Laboratories, a premiere cannabis testing
laboratory with headquarters in Jacksonville, Florida,
announced the addition of Wyman Dickey as Chief
Executive Officer (CEO). Dickey brings tremendous
experience to this role having worked at the senior leader-
ship level for 17 years in the highly regulated field of Wyman Dickey
career postsecondary education. His operational success in
overseeing both start-up and tenured institutions matches well with the financial and
managerial benchmarks facing Americanna Laboratories in the coming years. His ability
to secure high levels of satisfaction from clients and colleagues correlates with
Americanna’s desire to always exceed the expectations of customers. “Wyman Dickey
has established a strong history of success in both quality outcomes and financial per-
formance. In a field such as laboratory testing, you must maintain a high standard in
every aspect and he clearly is used to exceeding in this type of environment. We believe
this move will bring immediate results.” said Co-Founder David Perez.

Cresco Labs Announces Expiration

of HSR Act Waiting Period

for the Proposed Acquisition

of Bluma Wellness

Cresco Labs and Bluma Wellness Inc. announce the
expiration of the waiting period under the Hart-Scott-
Rodino Antitrust Improvements Act of 1976 (the “HSR
Act”), as amended, in respect to Cresco Labs’ pending
acquisition of Bluma (the “Transaction”). The waiting
period expired without the issuance of a so-called “second
request” by the United States Department of Justice
Antitrust Division (the “DOJ”). The Transaction is antici-
pated to close in the second quarter of 2021 and is subject
to certain closing conditions, including approval from the
State of Florida. “We look forward to completing the
remaining steps required to close the Transaction and are
excited to begin our work with the Bluma team to accel-
erate our growth in the Florida market,” said Charles Charles Bachtell
Bachtell, CEO of Cresco Labs.

Curaleaf Appoints Carlos Madrazo

as Senior Vice President Investor
Relations and Capital Markets

Curaleaf Holdings, Inc. announced that Carlos Madrazo has been appointed to the role
of Senior Vice President of Investor Relations and Capital
Markets for Curaleaf, a new position. Madrazo will work
with Curaleaf’s Executive Leadership Team to help advance
the knowledge and understanding of the Company’s strate-
gic positioning within global cannabis and consumer pack-
aged goods markets, the Company’s successful track record
for growth and execution, as well as the value creation
opportunity for shareholders. Madrazo will also assist in cor-
porate finance and strategic planning matters. Madrazo has
over 20 years of experience in investor relations, investment
banking and operations at an international level. Most
recently, he led Investor Relations and Sustainability for
Grupo Televisa, S.A.B. Prior to Televisa, Carlos held posi- Carlos Madrazo
tions with Tutv Llc as CFO, where he launched and co-managed a new business venture
and with ING Barings, where he led Latin American media and entertainment invest-
ment banking. Carlos also spent six years with Chase Securities in its Global Mergers and
Acquisitions Group.

Cannabis News Florida cannabisnewsflorida.com April 2021 29